Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is the most severe disorder within the spectrum of motor neuron diseases (MND) that has no effective treatment and a progressively fatal outcome. We have conducted two clinical trials to assess the safety and feasibility of intravenous (IV) and intrathe...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cell J
Main Authors: Nabavi, Seyed Massood, Arab, Leila, Jarooghi, Neda, Bolurieh, Tina, Abbasi, Fatemeh, Mardpour, Soura, Azimyian, Vajihe, Moeininia, Fatemeh, Maroufizadeh, Saman, Sanjari, Leila, Hosseini, Seyedeh Esmat, Aghdami, Nasser
פורמט: Artigo
שפה:Inglês
יצא לאור: Royan Institute 2019
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099146/
https://ncbi.nlm.nih.gov/pubmed/30124008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22074/cellj.2019.5370
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים